Issue 53, 2025, Issue in Progress

Correction: Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors

Abstract

Correction for ‘Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors’ by Berkant Kurban et al., RSC Adv., 2025, 15, 40897–40911, https://doi.org/10.1039/D5RA05397H.

Associated articles

Article information

Article type
Correction
Submitted
10 Nov 2025
Accepted
10 Nov 2025
First published
19 Nov 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 45295-45295

Correction: Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors

B. Kurban, B. N. Sağlık Özkan, D. Osmaniye, S. Levent, Y. Özkay and Z. A. Kaplancıklı, RSC Adv., 2025, 15, 45295 DOI: 10.1039/D5RA90135A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements